Evaluation Of Celecoxib In Combination With Weekly Docetaxel In Elderly (70 Years) Or Poor Performance Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2013
At a glance
- Drugs Celecoxib (Primary) ; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 20 Apr 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 20 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.